期刊文献+

Sigma值在建立室内质控允许误差中的应用探讨 被引量:1

Application Discussion of the Sigma Value in Establishment of Allowance Error of Internal Quanlity Control
下载PDF
导出
摘要 目的通过Sigma值的计算,建立适合现有质量体系的室内允许误差。方法依据EP5文件得出各检测项目的不精密度,同时根据参与美国病理家协会校准验证活动得出的各项目的斜率、截距,计算出各项目不同医学决定水平处的偏倚,得出各检测项目的Sigma值,若超出范围,则根据最适Sigma值对该项目的室内允许误差进行相应调整,最终得到适合各检测项目的允许误差。结果血清磷(P)、C-反应蛋白(CRP)、C4继续使用CLIA’88中规定的最大允许误差,IgA,IgG,IgM,C3,血清铁(Iron)的室内允许误差在CLIA’88规定的基础上有所缩减。结论该方法可与方法验证一起对检测系统的性能作出完整评价,并对标准中没有给出最大允许误差或室内变异较大的项目得出暂定的允许误差,同时通过室内质控、试剂批号验证的检验,达到质量持续性提升的最终目标。 Objective To establish suitable current quality system of detection for the internal allowable limits of error. Methods Obtained every test's imprecision according to EP5 doucument, and with participation of College of American Pathologists calibration verification that obtained the test of slope and intercept ,calculated the bias by the various medical decision level,accessed the Sigma value for the test. If the Sigma value out-of-scope,in accordance with the optimal value of the item,Sigma made some adjuste with internal allowable limits of error. Accordingly, finally obtaining suitable internal allowable limits of error. Results Serum phosphorus,C-reactive protein and complement 4 continued to use CLIA'88 stipulated in the maximum allowable error, immunoglobulin A, immunoglobulin G, immunoglobulin M, complement 3 and serum iron internal allowable limits of error on the basis of CLIA' 88 had to reduce. Conclusion The method can be together with the method validation make a complete evaluation of analysis system performance,while obtain the test tentative tolerances error which the standard can not given the maximum allowable error or variance larger ,through confirming internal quality control and the lots of reagents validation ,continuing to upgrade the quality of the ultimate goal.
出处 《现代检验医学杂志》 CAS 2008年第5期109-111,共3页 Journal of Modern Laboratory Medicine
基金 广州市科技攻关项目(编号2005Z1-E0071)
关键词 最大允许误差 不精密度 偏倚 allowable limits of error imprecision bias
  • 相关文献

参考文献5

  • 1Immunology Calibration Verfication/Linearity Participant Summary[S]. CAP2007LNT-B.
  • 2C-Reactive Protein Calibration Verfication/Linearity Participant Summary[S]. CAP2007LN12-B.
  • 3Chemistry/Lipid/Enzyme Calibration Verfication/Linearity Participant Summary[S]. CAP2007LN2-B.
  • 4Evaluation of Precision Performance of Clinical Chemistry Devices :Approved Guideline ,NCCLS, 1999.
  • 5Westgard. Form Method Validation to Six Sigma. http : / /www. westgard, com/lesson78, htm

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部